Skip to main content

Grace Therapeutics, Inc.

GRCE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001444192

In the last 90 days, Grace Therapeutics, Inc. insiders filed 4 open-market purchases and 0 sales; 33 institutions reported holding it in 13F filings for Q2 2026, worth $8.74M in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Grace Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
34
+13 vs. Q4 2025
Shares held
4.26M
+360.8K (+9.2%) vs. Q4 2025
Total value
$19.7M
+$6.23M (+46.1%) vs. Q4 2025
New holders
18
6 more added
Sold out
5
4 more reduced

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting GRCE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 34 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 14 institutionsQ4 2021: 13 institutionsQ1 2022: 9 institutionsQ2 2022: 10 institutionsQ3 2022: 9 institutionsQ4 2022: 9 institutionsQ1 2023: 12 institutionsQ2 2023: 11 institutionsQ3 2023: 12 institutionsQ4 2023: 9 institutionsQ1 2024: 10 institutionsQ2 2024: 12 institutionsQ3 2024: 12 institutionsQ4 2024: 15 institutionsQ1 2025: 17 institutionsQ2 2025: 20 institutionsQ3 2025: 20 institutionsQ4 2025: 23 institutionsQ1 2026: 34 institutionsQ2 2026: 33 institutions
Value heldQ1 2026: $19.7M
Q1 2021: $0Q2 2021: $0Q3 2021: $356.5KQ4 2021: $248.8KQ1 2022: $183.7KQ2 2022: $108.2KQ3 2022: $53.1KQ4 2022: $24.8KQ1 2023: $189.6KQ2 2023: $204.2KQ3 2023: $1.55MQ4 2023: $1.65MQ1 2024: $4.34MQ2 2024: $6.30MQ3 2024: $6.36MQ4 2024: $7.84MQ1 2025: $9.17MQ2 2025: $11.3MQ3 2025: $11.0MQ4 2025: $15.0MQ1 2026: $19.7MQ2 2026: $8.74M
Institutions holding GRCE and their total value by quarter
QuarterHoldersValue
Q2 202633$8.74M
Q1 202634$19.7M
Q4 202523$15.0M
Q3 202520$11.0M
Q2 202520$11.3M
Q1 202517$9.17M
Q4 202415$7.84M
Q3 202412$6.36M
Q2 202412$6.30M
Q1 202410$4.34M
Q4 20239$1.65M
Q3 202312$1.55M
Q2 202311$204.2K
Q1 202312$189.6K
Q4 20229$24.8K
Q3 20229$53.1K
Q2 202210$108.2K
Q1 20229$183.7K
Q4 202113$248.8K
Q3 202114$356.5K
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Grace Therapeutics, Inc.; share changes are against Q4 2025.

Institutions holding GRCE in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Cerity Partners LLC849,055$3.93M0.01%+426,323+100.8%Added
Eversept Partners, LP756,600$3.50M0.23%+756,600New
Nantahala Capital Management, LLC728,203$3.37M0.21%−450,000−38.2%Reduced
Bank of America Corp494,723$2.29M0.00%+250.0%Added
Vanguard Capital Management LLC401,656$1.86M0.00%+401,656New
Renaissance Technologies LLC243,910$1.13M0.00%+114,129+87.9%Added
Jane Street Group, LLC167,097$773.7K0.00%+167,097New
Citadel Advisors LLC98,742$457.2K0.00%+56,445+133.4%Added
Marshall Wace, LLP91,416$423.3K0.00%+91,416New
Connective Capital Management, LLC84,549$391.5K0.32%+84,549New
Quadrature Capital Ltd66,822$309.4K0.00%+66,822New
XTX Topco Ltd63,094$292.1K0.01%+32,833+108.5%Added
Birchview Capital, LP50,000$231.5K0.13%+50,000New
Diametric Capital, LP39,796$184.3K0.05%+39,796New
Pale Fire Capital SE37,762$174.8K0.02%+37,762New
UBS Group AG26,301$121.8K0.00%+26,301New
Kestra Private Wealth Services, LLC13,000$60.2K0.00%+13,000New
Prelude Capital Management, LLC10,074$46.6K0.00%+10,074New
Oppenheimer & Co Inc10,000$46.3K0.00%+10,000New
Vanguard Fiduciary Trust Co8,750$40.5K0.00%+8,750New
BNP Paribas Arbitrage, SA7,100$32.9K0.00%+6,500+1,083.3%Added
Group One Trading, L.P.5,000$23.1K0.00%+5,000New
Morgan Stanley4,548$21.1K0.00%−20,900−82.1%Reduced
National Bank of Canada2,716$12.6K0.00%00.0%Unchanged
Wells Fargo & Company1,800$8.33K0.00%+1,800New
Royal Bank of Canada543$3.00K0.00%00.0%Unchanged
SRS Capital Advisors, Inc.500$2.31K0.00%+500New
Tower Research Capital LLC (TRC)415$1.92K0.00%−1,530−78.7%Reduced
Activest Wealth Management104$4820.00%00.0%Unchanged
Caitong International Asset Management Co., Ltd82$3800.00%+82New
SBI Securities Co., Ltd.70$3240.00%−31−30.7%Reduced
Steward Partners Investment Advisory, LLC41$1900.00%00.0%Unchanged
NBC Securities, Inc.2$90.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec1$50.00%00.0%Unchanged
AIGH Capital Management LLC0$00.00%−907,217−100.0%Sold out
ADAR1 Capital Management, LLC0$00.00%−641,988−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−13,774−100.0%Sold out
Stratos Wealth Partners, LTD.0$00.00%−11,182−100.0%Sold out
Flagship Harbor Advisors, LLC0$00.00%−2−100.0%Sold out
Vanguard Group Inc––––Not filed
Motiv8 Investments LLC––––Not filed